Insider Stock Trading History of Bitterman Kevin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bitterman Kevin since year 2005. The trader's CIK number is 1591747. At the time of this reporting, Bitterman Kevin is the Director of Editas Medicine, Inc. . (stock ticker symbol EDIT). See this page for all insider trading activities at Editas Medicine, Inc. .

Note that in the past Bitterman Kevin also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bitterman Kevin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-22 EDIT Editas Medicine, Inc. Sale 1,000,000 17.00 17,000,000
2016-12-07 EDIT Editas Medicine, Inc. Sale 75,000 15.82 1,186,500
2016-12-05 EDIT Editas Medicine, Inc. Sale 80,000 15.74 1,259,200
2016-12-06 EDIT Editas Medicine, Inc. Sale 50,000 15.87 793,500
2016-11-23 EDIT Editas Medicine, Inc. Sale 21,480 15.71 337,450
2016-11-22 EDIT Editas Medicine, Inc. Sale 12,819 15.77 202,155
2016-11-16 EDIT Editas Medicine, Inc. Sale 30,830 16.30 502,529
2016-11-14 EDIT Editas Medicine, Inc. Sale 58,035 17.16 995,880
2016-11-15 EDIT Editas Medicine, Inc. Sale 30,865 17.16 529,797
2016-09-08 EDIT Editas Medicine, Inc. Sale 500,000 16.80 8,400,000
2014-02-10 GNCA Genocea Biosciences, Inc. Buy 232,820 12.00 2,793,840

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bitterman Kevin (Director of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.